blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2340051

EP2340051 - DRUG CARRIER PROVIDING MRI CONTRAST ENHANCEMENT [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.09.2016
Database last updated on 30.10.2024
Most recent event   Tooltip17.08.2018Lapse of the patent in a contracting state
New state(s): BG
published on 19.09.2018  [2018/38]
Applicant(s)For:AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HR  HU  IE  IS  IT  LI  LT  LU  LV  MC  MK  MT  NL  NO  PL  PT  RO  SE  SI  SK  SM  TR 
Koninklijke Philips N.V.
High Tech Campus 5
5656 AE Eindhoven / NL
For:DE 
Philips Intellectual Property & Standards GmbH
Lübeckertordamm 5
20099 Hamburg / DE
[2015/46]
Former [2013/39]For:AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HR  HU  IE  IS  IT  LI  LT  LU  LV  MC  MK  MT  NL  NO  PL  PT  RO  SE  SI  SK  SM  TR 
Koninklijke Philips N.V.
High Tech Campus 5
5656 AE Eindhoven / NL
For:DE 
Philips Intellectual Property & Standards GmbH
Lübeckertordamm 5
20099 Hamburg / DE
Former [2011/27]For:AT  BE  BG  CH  CY  CZ  DK  EE  ES  FI  FR  GB  GR  HR  HU  IE  IS  IT  LI  LT  LU  LV  MC  MK  MT  NL  NO  PL  PT  RO  SE  SI  SK  SM  TR 
Koninklijke Philips Electronics N.V.
Groenewoudseweg 1
5621 BA Eindhoven / NL
For:DE 
Philips Intellectual Property & Standards GmbH
Lübeckertordamm 5
20099 Hamburg / DE
Inventor(s)01 / LANGEREIS, Sander
c/o High Tech Campus Building 44
NL-5656 AE Eindhoven / NL
02 / KEUPP, Jochen
c/o High Tech Campus Building 44
NL-5656 AE Eindhoven / NL
03 / GRUELL, Holger
c/o High Tech Campus Building 44
NL-5656 AE Eindhoven / NL
04 / BURDINSKI, Dirk
c/o High Tech Campus Building 44
NL-5656 AE Eindhoven / NL
05 / BEELEN, Danielle
c/o High Tech Campus Building 44
NL-5656 AE Eindhoven / NL
 [2011/27]
Representative(s)Kroeze, Johannes Antonius
Philips Intellectual Property & Standards
High Tech Campus 5
5656 AE Eindhoven / NL
[N/P]
Former [2015/46]Kroeze, Johannes Antonius
Philips
Intellectual Property & Standards
P.O. Box 220
5600 AE Eindhoven / NL
Former [2011/27]Kroeze, Johannes Antonius
Philips Intellectual Property & Standards P.O. Box 220
5600 AE Eindhoven / NL
Application number, filing date09787082.803.09.2009
[2011/27]
WO2009IB53836
Priority number, dateEP2008016409110.09.2008         Original published format: EP 08164091
[2011/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010029469
Date:18.03.2010
Language:EN
[2010/11]
Type: A1 Application with search report 
No.:EP2340051
Date:06.07.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 18.03.2010 takes the place of the publication of the European patent application.
[2011/27]
Type: B1 Patent specification 
No.:EP2340051
Date:11.11.2015
Language:EN
[2015/46]
Search report(s)International search report - published on:EP18.03.2010
ClassificationIPC:A61K49/06, A61K49/18, A61K9/127
[2011/27]
CPC:
A61K49/08 (EP,US); A61K41/0028 (EP,US); A61K49/10 (EP,US);
A61K49/12 (EP,US); A61K49/1812 (EP,US); A61K9/127 (EP,US);
A61K9/1271 (EP,US); A61P35/00 (EP); A61P43/00 (EP);
A61P9/00 (EP); A61K9/1273 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2015/46]
Former [2011/27]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:WIRKSTOFFTRÄGER FÜR VERBESSERTEN MRI-KONTRAST[2011/27]
English:DRUG CARRIER PROVIDING MRI CONTRAST ENHANCEMENT[2011/27]
French:VECTEUR DE MÉDICAMENT APPORTANT UNE AMÉLIORATION DE CONTRASTE EN IRM[2011/27]
Entry into regional phase11.04.2011National basic fee paid 
11.04.2011Designation fee(s) paid 
11.04.2011Examination fee paid 
Examination procedure11.04.2011Examination requested  [2011/27]
14.07.2011Amendment by applicant (claims and/or description)
19.01.2012Despatch of a communication from the examining division (Time limit: M04)
05.07.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
22.08.2012Reply to a communication from the examining division
30.03.2015Cancellation of oral proceeding that was planned for 21.04.2015
21.04.2015Date of oral proceedings (cancelled)
08.05.2015Communication of intention to grant the patent
24.08.2015Fee for grant paid
24.08.2015Fee for publishing/printing paid
24.08.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  19.01.2012
Opposition(s)12.08.2016No opposition filed within time limit [2016/42]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
22.08.2012Request for further processing filed
22.08.2012Full payment received (date of receipt of payment)
Request granted
06.09.2012Decision despatched
Fees paidRenewal fee
30.09.2011Renewal fee patent year 03
01.10.2012Renewal fee patent year 04
30.09.2013Renewal fee patent year 05
30.09.2014Renewal fee patent year 06
30.09.2015Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.09.2009
AT11.11.2015
BE11.11.2015
BG11.11.2015
CY11.11.2015
CZ11.11.2015
DK11.11.2015
EE11.11.2015
ES11.11.2015
FI11.11.2015
HR11.11.2015
IT11.11.2015
LT11.11.2015
LV11.11.2015
MC11.11.2015
MK11.11.2015
NL11.11.2015
PL11.11.2015
RO11.11.2015
SE11.11.2015
SI11.11.2015
SK11.11.2015
SM11.11.2015
TR11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
[2018/38]
Former [2018/33]HU03.09.2009
AT11.11.2015
BE11.11.2015
CY11.11.2015
CZ11.11.2015
DK11.11.2015
EE11.11.2015
ES11.11.2015
FI11.11.2015
HR11.11.2015
IT11.11.2015
LT11.11.2015
LV11.11.2015
MC11.11.2015
MK11.11.2015
NL11.11.2015
PL11.11.2015
RO11.11.2015
SE11.11.2015
SI11.11.2015
SK11.11.2015
SM11.11.2015
TR11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
Former [2018/29]HU03.09.2009
AT11.11.2015
BE11.11.2015
CY11.11.2015
CZ11.11.2015
DK11.11.2015
EE11.11.2015
ES11.11.2015
FI11.11.2015
HR11.11.2015
IT11.11.2015
LT11.11.2015
LV11.11.2015
MC11.11.2015
MK11.11.2015
NL11.11.2015
PL11.11.2015
RO11.11.2015
SE11.11.2015
SI11.11.2015
SK11.11.2015
SM11.11.2015
TR11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
Former [2018/28]HU03.09.2009
AT11.11.2015
BE11.11.2015
CY11.11.2015
CZ11.11.2015
DK11.11.2015
EE11.11.2015
ES11.11.2015
FI11.11.2015
HR11.11.2015
IT11.11.2015
LT11.11.2015
LV11.11.2015
MC11.11.2015
MK11.11.2015
NL11.11.2015
PL11.11.2015
RO11.11.2015
SE11.11.2015
SI11.11.2015
SK11.11.2015
SM11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
Former [2017/31]AT11.11.2015
BE11.11.2015
CZ11.11.2015
DK11.11.2015
EE11.11.2015
ES11.11.2015
FI11.11.2015
HR11.11.2015
IT11.11.2015
LT11.11.2015
LV11.11.2015
MC11.11.2015
NL11.11.2015
PL11.11.2015
RO11.11.2015
SE11.11.2015
SI11.11.2015
SK11.11.2015
SM11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
Former [2017/03]AT11.11.2015
BE11.11.2015
CZ11.11.2015
DK11.11.2015
EE11.11.2015
ES11.11.2015
FI11.11.2015
HR11.11.2015
IT11.11.2015
LT11.11.2015
LV11.11.2015
NL11.11.2015
PL11.11.2015
RO11.11.2015
SE11.11.2015
SI11.11.2015
SK11.11.2015
SM11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
Former [2016/49]AT11.11.2015
CZ11.11.2015
DK11.11.2015
EE11.11.2015
ES11.11.2015
FI11.11.2015
HR11.11.2015
IT11.11.2015
LT11.11.2015
LV11.11.2015
NL11.11.2015
PL11.11.2015
RO11.11.2015
SE11.11.2015
SI11.11.2015
SK11.11.2015
SM11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
Former [2016/39]AT11.11.2015
CZ11.11.2015
DK11.11.2015
EE11.11.2015
ES11.11.2015
FI11.11.2015
HR11.11.2015
IT11.11.2015
LT11.11.2015
LV11.11.2015
NL11.11.2015
PL11.11.2015
RO11.11.2015
SE11.11.2015
SK11.11.2015
SM11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
Former [2016/38]AT11.11.2015
CZ11.11.2015
EE11.11.2015
ES11.11.2015
FI11.11.2015
HR11.11.2015
IT11.11.2015
LT11.11.2015
LV11.11.2015
NL11.11.2015
PL11.11.2015
RO11.11.2015
SE11.11.2015
SK11.11.2015
SM11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
Former [2016/36]AT11.11.2015
CZ11.11.2015
EE11.11.2015
ES11.11.2015
FI11.11.2015
HR11.11.2015
IT11.11.2015
LT11.11.2015
LV11.11.2015
NL11.11.2015
PL11.11.2015
RO11.11.2015
SE11.11.2015
SK11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
Former [2016/34]AT11.11.2015
CZ11.11.2015
ES11.11.2015
FI11.11.2015
HR11.11.2015
IT11.11.2015
LT11.11.2015
LV11.11.2015
NL11.11.2015
PL11.11.2015
SE11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
Former [2016/25]AT11.11.2015
ES11.11.2015
FI11.11.2015
HR11.11.2015
IT11.11.2015
LT11.11.2015
LV11.11.2015
NL11.11.2015
PL11.11.2015
SE11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
Former [2016/24]AT11.11.2015
ES11.11.2015
FI11.11.2015
HR11.11.2015
IT11.11.2015
LT11.11.2015
NL11.11.2015
PL11.11.2015
SE11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
Former [2016/23]ES11.11.2015
HR11.11.2015
IT11.11.2015
LT11.11.2015
NL11.11.2015
SE11.11.2015
NO11.02.2016
IS11.03.2016
Former [2016/22]ES11.11.2015
IT11.11.2015
LT11.11.2015
NL11.11.2015
NO11.02.2016
IS11.03.2016
Former [2016/21]ES11.11.2015
IT11.11.2015
LT11.11.2015
NO11.02.2016
Former [2016/20]ES11.11.2015
LT11.11.2015
Cited inInternational search[PX]EP1985312  (KONINKL PHILIPS ELECTRONICS NV [NL]) [PX] 1-19 * paragraphs [0011] , [0012] , [0020] *;
 [XY]WO2007141767  (KONINKL PHILIPS ELECTRONICS NV [NL], et al) [X] 1-19 * pages 5,6 * * page 15, lines 15-17; figure 1 * [Y] 4;
 [X]US2003185760  (LANZA GREGORY [US], et al) [X] 1-19 * paragraphs [0021] , [0035] , [0041] , [0081]; example 3 * * paragraph [0058] *;
 [X]US2007237721  (LANZA GREGORY M [US], et al) [X] 1-19 * paragraphs [0037] , [0038] , [0040] , [0045]; example - *;
 [Y]WO2006032705  (GUERBET SA [FR], et al) [Y] 4 * page 9, line 15 - line 24 * * page 11, line 16 - line 35 *
 [X]  - MORAWSKI A M ET AL, "Quantitative magnetic resonance immunohistochemistry with ligand-targeted 19F nanoparticles", MAGNETIC RESONANCE IN MEDICINE, ACADEMIC PRESS, DULUTH, MN, US, (20041201), vol. 52, no. 6, ISSN 0740-3194, pages 1255 - 1262, XP002391116 [X] 1-19 * the whole document *

DOI:   http://dx.doi.org/10.1002/mrm.20287
 [X]  - LANZA G M ET AL, "Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis", CIRCULATION, LIPPINCOT WILLIAMS AND WILKINS, BALTIMORE, US, (20021126), vol. 106, no. 22, ISSN 1524-4539, pages 2842 - 2847, XP002391118 [X] 1-19 * the whole document *

DOI:   http://dx.doi.org/10.1161/01.CIR.0000044020.27990.32
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.